LUPINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 5.000
AS - Asia 2.354
EU - Europa 1.785
SA - Sud America 307
Continente sconosciuto - Info sul continente non disponibili 105
AF - Africa 52
OC - Oceania 3
Totale 9.606
Nazione #
US - Stati Uniti d'America 4.864
SG - Singapore 877
CN - Cina 572
IT - Italia 417
DE - Germania 294
VN - Vietnam 281
PL - Polonia 273
BR - Brasile 228
FI - Finlandia 189
HK - Hong Kong 175
GB - Regno Unito 156
TR - Turchia 132
UA - Ucraina 103
CA - Canada 72
SE - Svezia 68
FR - Francia 62
BD - Bangladesh 56
IN - India 53
JP - Giappone 49
ID - Indonesia 45
MX - Messico 43
RU - Federazione Russa 43
NL - Olanda 33
BE - Belgio 31
AR - Argentina 27
RO - Romania 21
CZ - Repubblica Ceca 19
ZA - Sudafrica 19
IQ - Iraq 18
AT - Austria 16
ES - Italia 15
PK - Pakistan 13
CO - Colombia 12
LT - Lituania 12
IE - Irlanda 10
CL - Cile 9
EC - Ecuador 9
TN - Tunisia 9
EG - Egitto 8
VE - Venezuela 8
IR - Iran 7
MY - Malesia 7
PH - Filippine 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
PE - Perù 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
CR - Costa Rica 5
DZ - Algeria 5
KZ - Kazakistan 5
OM - Oman 5
AL - Albania 4
JM - Giamaica 4
JO - Giordania 4
KE - Kenya 4
NP - Nepal 4
AU - Australia 3
GR - Grecia 3
LV - Lettonia 3
MA - Marocco 3
TW - Taiwan 3
BH - Bahrain 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IL - Israele 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
NO - Norvegia 2
PA - Panama 2
PY - Paraguay 2
QA - Qatar 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
KY - Cayman, isole 1
LU - Lussemburgo 1
MN - Mongolia 1
MQ - Martinica 1
MT - Malta 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 9.499
Città #
Ashburn 619
Singapore 523
Fairfield 430
San Jose 371
Woodbridge 350
Warsaw 271
Houston 230
Ann Arbor 223
Beijing 216
Chandler 203
Santa Clara 185
Seattle 178
Hong Kong 174
Munich 171
Cambridge 135
Wilmington 128
Jacksonville 126
Council Bluffs 120
New York 117
Ferrara 114
Helsinki 113
Dallas 110
Ho Chi Minh City 95
Los Angeles 77
Izmir 66
Milan 60
Hanoi 53
Tokyo 49
Turku 47
Shanghai 46
Nanjing 45
Princeton 37
Jakarta 36
Orem 36
Lauterbourg 34
Brussels 31
Phoenix 29
Buffalo 28
London 28
Boardman 27
Mexico City 27
San Diego 27
Chicago 26
Tianjin 23
São Paulo 22
Nanchang 21
Rome 21
Toronto 21
Atlanta 20
Montreal 20
Bologna 19
Bremen 19
Brooklyn 18
Denver 18
Addison 17
Da Nang 17
Timisoara 17
Falls Church 16
Amsterdam 14
Chennai 14
Johannesburg 14
Brno 13
Dong Ket 13
Shenyang 13
The Dalles 13
Changsha 12
Haiphong 12
Nuremberg 12
Manchester 11
San Francisco 11
Stockholm 11
Boston 10
Dublin 10
Poplar 10
Redwood City 10
Rio de Janeiro 10
Charlotte 9
Dearborn 9
Hebei 9
Moscow 9
Washington 9
Barnet 8
Columbus 8
Frankfurt am Main 8
Kunming 8
Naples 8
Philadelphia 7
Santiago 7
Ankara 6
Auburn Hills 6
Baghdad 6
Belo Horizonte 6
Falkenstein 6
Hangzhou 6
Hefei 6
Jiaxing 6
Mountain View 6
Salt Lake City 6
Tampa 6
Vienna 6
Totale 6.684
Nome #
Absolute quantification of cell-free microRNAs in cancer patients 341
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 324
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 318
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 309
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 307
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 304
Ruolo del miR-221 nella tumorigenesi epatica 284
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 282
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 278
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 275
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 269
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 257
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 253
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 253
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 250
Circulating non-coding RNA as biomarkers in colorectal cancer 245
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 245
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 237
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 235
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 231
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 231
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 224
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 222
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 218
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 212
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 212
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 199
Mutated beta-catenin evades a microRNA-dependent regulatory loop 194
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 193
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 190
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 178
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 178
Oncogenic role of miR-483-3p at the IGF2/483 locus 176
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 174
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 173
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy 171
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 168
The importance of microRNAs in RAS oncogenic activation in human cancer 160
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing 150
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 134
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 123
null 89
null 77
null 63
Totale 9.606
Categoria #
all - tutte 41.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.780
Totale 43.456


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022398 0 0 30 23 23 23 45 24 16 33 53 128
2022/2023474 48 41 29 67 66 72 35 31 52 2 17 14
2023/2024332 28 36 11 5 31 85 16 28 7 8 5 72
2024/20251.520 35 35 95 78 147 171 93 69 309 114 183 191
2025/20263.580 389 135 267 394 502 242 488 220 386 323 168 66
2026/2027341 89 166 86 0 0 0 0 0 0 0 0 0
Totale 9.606